Evidence map›Paper›PMID 31596434›Full record

ArticleJAMA psychiatry2020

Comparison of the Association Between Goal-Directed Planning and Self-reported Compulsivity vs Obsessive-Compulsive Disorder Diagnosis.

Claire M Gillan, Eyal Kalanthroff, Michael Evans, Hilary M Weingarden, Ryan J Jacoby, Marina Gershkovich, Ivar Snorrason, Raphael Campeas, Cynthia Cervoni, Nicholas Charles Crimarco and 9 more

Erratum issued Registry-linked trialAbstract readComparative Study
In one paragraph

Article in JAMA psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT05546658 (Effects of Psilocybin in Obsessive Compulsive Disorder), which is not on this map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05546658 early_phase1active not recruitingnot on this mapstarted 2022, after this paper: background citation

Effects of Psilocybin in Obsessive Compulsive Disorder

TypeinterventionalSponsorJohns Hopkins UniversityRan2022 to 2027Enrolled35ConditionsObsessive-Compulsive DisorderArmsPsilocybin
3 · Its place in the literature

Who cites it

48 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. The amygdala and the pursuit of future rewards.Frontiers in neuroscience · 2024
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Claire M GillanSchool of Psychology, Trinity College Institute of Neuroscience and Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland.
Eyal KalanthroffDepartment of Psychology, The Hebrew University of Jerusalem, Mount Scopus, Israel.
Michael EvansDepartment of Psychology, New York University, New York.
Hilary M WeingardenDepartment of Psychiatry, Massachusetts General Hospital, Boston.
Ryan J JacobyDepartment of Psychiatry, Massachusetts General Hospital, Boston.
Marina GershkovichDepartment of Psychiatry, Columbia Irving University Medical Center, New York, New York.
Ivar SnorrasonDepartment of Psychiatry, Harvard Medical School, Boston, Massachusetts.
Raphael CampeasDepartment of Psychiatry, Columbia Irving University Medical Center, New York, New York.
Cynthia CervoniDepartment of Psychiatry, Stony Brook University, Stony Brook, New York.
Nicholas Charles CrimarcoDepartment of Psychiatry, Columbia Irving University Medical Center, New York, New York.
Yosef SokolVISN 2 Mental Illness Research Education and Clinical Centers, New York, New York.
Sarah L GarnaatWarren Alpert Medical School of Brown University, Providence, Rhode Island.
Nicole C R McLaughlinWarren Alpert Medical School of Brown University, Providence, Rhode Island.
Elizabeth A PhelpsDepartment of Psychology, Harvard University, Cambridge, Massachusetts.
Anthony PintoDepartment of Psychiatry, Hofstra Northwell School of Medicine, Hempstead, New York.
Christina L BoisseauDepartment of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Sabine WilhelmDepartment of Psychiatry, Massachusetts General Hospital, Boston.
Nathaniel D DawPrinceton Neuroscience Institute, Department of Psychology, Princeton University, Princeton, New Jersey.
H B SimpsonDepartment of Psychiatry, Columbia Irving University Medical Center, New York, New York.

Funding

Neuroanatomical Changes After Ventral Capsulotomy for Intractable OCD: A TranslatK23MH100607 · NIMH · BUTLER HOSPITAL (PROVIDENCE, RI) · PI MCLAUGHLIN, NICOLE CR · 2014 to 2017
$740k
NIMH NIH HHS K23 MH100607
6 · The paper itself

Abstract

Importance: Dimensional definitions of transdiagnostic mental health problems have been suggested as an alternative to categorical diagnoses, having the advantage of capturing heterogeneity within diagnostic categories and similarity across them and bridging more naturally psychological and neural substrates. Objective: To examine whether a self-reported compulsivity dimension has a stronger association with goal-directed and related higher-order cognitive deficits compared with a diagnosis of obsessive-compulsive disorder (OCD). Design, Setting, and Participants: In this cross-sectional study, patients with OCD and/or generalized anxiety disorder (GAD) from across the United States completed a telephone-based diagnostic interview by a trained rater, internet-based cognitive testing, and self-reported clinical assessments from October 8, 2015, to October 1, 2017. Follow-up data were collected to test for replicability. Main Outcomes and Measures: Performance was measured on a test of goal-directed planning and cognitive flexibility (Wisconsin Card Sorting Test [WCST]) and a test of abstract reasoning. Clinical variables included DSM-5 diagnosis of OCD and GAD and 3 psychiatric symptom dimensions (general distress, compulsivity, and obsessionality) derived from a factor analysis. Results: Of 285 individuals in the analysis (mean [SD] age, 32 [12] years; age range, 18-77 years; 219 [76.8%] female), 111 had OCD; 82, GAD; and 92, OCD and GAD. A diagnosis of OCD was not associated with goal-directed performance compared with GAD at baseline (β [SE], -0.02 [0.02]; P = .18). In contrast, a compulsivity dimension was negatively associated with goal-directed performance (β [SE], -0.05 [0.02]; P = .003). Results for abstract reasoning task and WCST mirrored this pattern; the compulsivity dimension was associated with abstract reasoning (β [SE], 2.99 [0.63]; P < .001) and several indicators of WCST performance (eg, categories completed: β [SE], -0.57 [0.09]; P < .001), whereas OCD diagnosis was not (abstract reasoning: β [SE], 0.39 [0.66]; P = .56; categories completed: β [SE], -0.09 [0.10]; P = .38). Other symptom dimensions relevant to OCD, obsessionality, and general distress had no reliable association with goal-directed performance, WCST, or abstract reasoning. Obsessionality had a positive association with requiring more trials to reach the first category on the WCST at baseline (β [SE], 2.92 [1.39]; P = .04), and general distress was associated with impaired goal-directed performance at baseline (β [SE],-0.04 [0.02]; P = .01). However, unlike the key results of this study, neither survived correction for multiple comparisons or was replicated at follow-up testing. Conclusions and Relevance: Deficits in goal-directed planning in OCD may be more strongly associated with a compulsivity dimension than with OCD diagnosis. This result may have implications for research assessing the association between brain mechanisms and clinical manifestations and for understanding the structure of mental illness.

Indexed as

AdolescentAdultAgedAnxiety DisordersCompulsive BehaviorCross-Sectional StudiesFemaleGoalsHumansInterview, PsychologicalMaleMiddle AgedObsessive-Compulsive DisorderPsychiatric Status Rating ScalesSelf ReportWisconsin Card Sorting Test

Identifiers

PMID31596434
PMCPMC6802255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.